Get started
KREBS BIOCHEMICALS & INDKREBS BIOCHEMICALS & INDKREBS BIOCHEMICALS & IND

KREBS BIOCHEMICALS & IND

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

KREBSBIO chart


Full chart

Key stats


Market capitalization
‪1.73 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−11.37 INR
Net income (FY)
‪−197.28 M‬ INR
Revenue (FY)
‪507.16 M‬ INR
Shares float
—
Beta (1Y)
1.60

Employees


Employees (FY)
191
Change (1Y)
−19 −9.05%
Revenue / Employee (1Y)
‪2.66 M‬ INR
Net income / Employee (1Y)
‪−1.03 M‬ INR

About KREBS BIOCHEMICALS & IND


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jitendra Shah
Website
krebsbiochem.com
Headquarters
Hyderabad
Founded
1991
ISIN
INE268B01013
FIGI
BBG000DC0HZ2
Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. Its products include Androstenedione, Lovastatin, and Simvastatin. The company was founded by Ravindranath Tagore Ravi on December 2, 1991, and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

KREBSBIO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as KREBSBIO.

Frequently Asked Questions


The current price of KREBSBIO is 80.25 INR — it has increased by 3.36% in the past 24 hours. Watch KREBS BIOCHEMICALS & IND stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange KREBS BIOCHEMICALS & IND stocks are traded under the ticker KREBSBIO.
KREBSBIO stock has risen by 7.67% compared to the previous week, the month change is a 7.67% rise, over the last year KREBS BIOCHEMICALS & IND has showed a 11.30% increase.
KREBSBIO reached its all-time high on Mar 11, 1999 with the price of 253.02 INR, and its all-time low was 50.65 INR and was reached on Mar 29, 2023. View more price dynamics on KREBSBIO chart.
See other stocks reaching their highest and lowest prices.
KREBSBIO stock is 4.24% volatile and has beta coefficient of 1.60. Track KREBS BIOCHEMICALS & IND stock price on the chart and check out the list of the most volatile stocks — is KREBS BIOCHEMICALS & IND there?
Today KREBS BIOCHEMICALS & IND has the market capitalization of ‪1.73 B‬, it has increased by 5.10% over the last week.
Yes, you can track KREBS BIOCHEMICALS & IND financials in yearly and quarterly reports right on TradingView.
KREBSBIO net income for the last quarter is ‪−77.39 M‬ INR, while the quarter before that showed ‪−57.61 M‬ INR of net income which accounts for −34.34% change. Track more KREBS BIOCHEMICALS & IND financial stats to get the full picture.
No, KREBSBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 25, 2025, the company has 191 employees. See our rating of the largest employees — is KREBS BIOCHEMICALS & IND on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KREBS BIOCHEMICALS & IND EBITDA is ‪−127.36 M‬ INR, and current EBITDA margin is −16.62%. See more stats in KREBS BIOCHEMICALS & IND financial statements.
Like other stocks, KREBSBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KREBS BIOCHEMICALS & IND stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KREBS BIOCHEMICALS & IND technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KREBS BIOCHEMICALS & IND stock shows the sell signal. See more of KREBS BIOCHEMICALS & IND technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.